Pershing Edward

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
PROVECTUS BIOPHARMACEUTICALS, INC.CEOOption exercisenothing paid13,216 sharesSep 18, 2026PROVECTUS BIOPHARMACEUTICALS, INC.CEOnothing paidExercise · Sep 18Option exercise13,216Sep 18, 2026
PROVECTUS BIOPHARMACEUTICALS, INC.CEOOption exercisenothing paid13,216 sharesSep 11, 2026PROVECTUS BIOPHARMACEUTICALS, INC.CEOnothing paidExercise · Sep 11Option exercise13,216Sep 11, 2026
PROVECTUS BIOPHARMACEUTICALS, INC.CEOOption exercisenothing paid11,328 sharesSep 8, 2026PROVECTUS BIOPHARMACEUTICALS, INC.CEOnothing paidExercise · Sep 8Option exercise11,328Sep 8, 2026
PROVECTUS BIOPHARMACEUTICALS, INC.CEOOption exercisenothing paid11,328 sharesAug 26, 2026PROVECTUS BIOPHARMACEUTICALS, INC.CEOnothing paidExercise · Aug 26Option exercise11,328Aug 26, 2026
PROVECTUS BIOPHARMACEUTICALS, INC.CEOAwardnothing paid45,860 sharesJul 2, 2026PROVECTUS BIOPHARMACEUTICALS, INC.CEOnothing paidAward · Jul 2Award45,860Jul 2, 2026